Sep 17, 2020

Implantable Cardioverter Defibrillators (ICDs)

Information about devices surgically implanted in the chest to continuously monitor hearts that tend to beat dangerously fast and deliver corrective electrical impulses when required. An ICD is often known as 'an emergency room in your chest.'

The following media kits are made available to provide reporters with background information on the range of Medtronic therapies and the conditions they treat.

	Oct 13, 2016 Medtronic Cardiac Devices Gain FDA Approval to Enable Patient Access to the Most Advanced Diagnostic Imaging Patients with SureScan® Pacemakers, ICDs and CRT-Ds Now Can Receive 3 Tesla MRI Scans DUBLIN - Oct. 13, 2016 - Medtronic plc (NYSE:MDT) is the first company to receive U.S. Food and Drug Administration (FDA) approval for its suite of cardiac rhythm and heart failure devices and...
	May 2, 2016 Medtronic Receives FDA Approval for New Single-Chamber ICDs That Detect Atrial Fibrillation Visia AF MRI(TM) SureScan® and Visia AF(TM)ICDs Treat Dangerous Heart Rhythms and Enable Physicians to Identify Patients at Increased Risk for Stroke and Heart Failure Due to AF DUBLIN - May 2, 2016 - Medtronic plc (NYSE: MDT) today announced it has received U.S. Food and Drug Administration (FDA) approval for the Visia AF MRI(TM) SureScan® and Visia AF(TM)...
	May 10, 2014 New Data Show That Defibrillators Programmed to Wait Longer to Deliver Therapy Are Safe for Secondary Prevention ICD Patients with Medtronic SmartShock Technology Late-breaking Clinical Trial Data Confirm Industry Leadership with 1 Percent Inappropriate Shocks Using Medtronic SmartShock Technology MINNEAPOLIS and SAN FRANCISCO - May 10, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the results from the first prospective randomized clinical trial to show that Medtronic implantable...
	May 13, 2010 Late Breaking Clinical Trial Validates Value of Shock Reduction Strategies New Medtronic Evidence on Shock Reduction Device Programming Strategies Released At Heart Rhythm 2010 MINNEAPOLIS & DENVER, May 13, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) today released new evidence demonstrating that key shock-reduction programming strategies significantly reduced...
	May 13, 2010 Medtronic Data Show Effectiveness of Shock Reduction Technologies in Further Reducing Inappropriate Shocks Results of Virtual ICD Study Presented at Heart Rhythm 2010 MINNEAPOLIS & DENVER, May 13, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) released the Virtual ICD study data today that predicted 98 percent of studied implantable defibrillator patients...
	Sep 14, 2015 Medtronic First to Receive FDA Approval for MR-Conditional Implantable Cardioverter Defibrillator System Evera MRI ICD System Approved for Use During Full Body MRI Scans for Patients at Risk of Sudden Cardiac Arrest DUBLIN - Sept. 14, 2015 - Medtronic plc (NYSE: MDT) today announced that it has received the first U.S. Food and Drug Administration (FDA) approval for an implantable cardioverter defibrillator...
	Jan 29, 2015 Studies Show Benefits of Medtronic SmartShock(TM) Technology and Physician Reports in Protecting Patients from Inappropriate Shocks New Results from PainFree SST, Shock-Less Studies, Involving Nearly 7,000 Patients, Published in HeartRhythm DUBLIN and MINNEAPOLIS - Jan. 29, 2015 - Medtronic plc (NYSE: MDT) today announced new results from the PainFree SST and Shock-Less clinical studies published in the journal HeartRhythm. The data...